A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda
- PMID: 25754568
- DOI: 10.1016/j.gheart.2014.10.001
A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda
Abstract
Background: Rheumatic heart disease (RHD) is the most common cause of heart disease among Ugandans age 15 to 49 years. Secondary prophylaxis with monthly injection of benzathine penicillin is effective in preventing recurrence of acute rheumatic fever and worsening of RHD, but adherence rates are poor in Uganda.
Objectives: This study sought to identify health behaviors, attitudes, and health care system factors that influence adherence to RHD secondary prophylaxis.
Methods: We conducted 5 structured focus groups with 36 participants on monthly penicillin injections for RHD in Kamplala, Uganda. Transcripts were analyzed using qualitative description analysis and health behavior models.
Results: Most participants were female (64%), from an urban area (81%), and had family income less than US$1 daily (69%). Ages ranged from 14 to 58 years. Median prophylaxis duration was 1.42 years and 58% were adherent (≥80% of injections). Key facilitators include perceived worsening of disease with missing injections, personal motivation, a reminder system for injections, supportive family and friends, and a positive relationship with health care providers. Barriers to adherence include lack of resources for transportation and medications, fear of injection pain, poor patient-provider communication, and poor availability of clinics and providers able to give injections.
Conclusions: We identified key facilitators and barriers to secondary prophylaxis for RHD from the patient perspective framed within the socioecological model. Our findings provide direction for intervention development to improve national RHD secondary prophylaxis.
Copyright © 2015 World Heart Federation (Geneva). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Acceptability and Implementation Challenges of Benzathine Penicillin G Secondary Prophylaxis for Rheumatic Heart Disease in Ethiopia: A Qualitative Study.Glob Heart. 2025 Jan 29;20(1):8. doi: 10.5334/gh.1393. eCollection 2025. Glob Heart. 2025. PMID: 39896316 Free PMC article.
-
Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.Cardiovasc J Afr. 2013 May;24(4):124-9. doi: 10.5830/CVJA-2013-022. Cardiovasc J Afr. 2013. PMID: 24217043 Free PMC article.
-
Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.Am Heart J. 2019 Sep;215:95-105. doi: 10.1016/j.ahj.2019.06.001. Epub 2019 Jun 8. Am Heart J. 2019. PMID: 31301533
-
Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.Cardiol Rev. 2016 Mar-Apr;24(2):94-8. doi: 10.1097/CRD.0000000000000065. Cardiol Rev. 2016. PMID: 25807106 Review.
-
Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.World J Pediatr Congenit Heart Surg. 2013 Oct;4(4):380-4. doi: 10.1177/2150135113497240. World J Pediatr Congenit Heart Surg. 2013. PMID: 24327631 Review.
Cited by
-
Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.Drug Deliv Transl Res. 2016 Oct;6(5):572-8. doi: 10.1007/s13346-016-0313-z. Drug Deliv Transl Res. 2016. PMID: 27465618
-
Adherence to Secondary Prophylaxis Among Patients with Acute Rheumatic Fever and Rheumatic Heart Disease.Curr Cardiol Rev. 2019;15(3):239-241. doi: 10.2174/1573403X1503190506120953. Curr Cardiol Rev. 2019. PMID: 31084592 Free PMC article.
-
Rheumatic Heart Disease Patients' Adherence to Secondary Prophylaxis and Associated Factors at Hospitals in Jimma Zone, Southwest Ethiopia: A Multicenter Study.Patient Prefer Adherence. 2020 Dec 4;14:2399-2406. doi: 10.2147/PPA.S281413. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 33304095 Free PMC article.
-
Study protocol for controlled human infection for penicillin G against Streptococcus pyogenes: a double-blinded, placebo-controlled, randomised trial to determine the minimum concentration required to prevent experimental pharyngitis (the CHIPS trial).BMJ Open. 2022 Dec 8;12(12):e064022. doi: 10.1136/bmjopen-2022-064022. BMJ Open. 2022. PMID: 36600395 Free PMC article.
-
Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.Glob Health Res Policy. 2021 Oct 2;6(1):35. doi: 10.1186/s41256-021-00222-2. Glob Health Res Policy. 2021. PMID: 34598719 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical